HWA
GOSS icon

HCR Wealth Advisors’s Gossamer Bio GOSS Stock Holding History

HCR Wealth Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,000
Closed -$20.1K – 227
2023
Q4 		$20.1K Buy
+22,000
New +$16.3K ﹤0.01% 205

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HCR Wealth Advisors's GOSS Position: Q1 2024 in Review

HCR Wealth Advisors sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 22,000 shares — an estimated $20.1K sold.

HCR Wealth Advisors first reported a position in GOSS in Q4 2023 and held it in 1 quarter. The position peaked at $20.1K in Q4 2023. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • HCR Wealth Advisors reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • HCR Wealth Advisors sold 22,000 Gossamer Bio shares in Q1 2024, an estimated $20.1K.
  • HCR Wealth Advisors first reported a position in Gossamer Bio in Q4 2023 and held it in 1 quarter.
  • HCR Wealth Advisors's Gossamer Bio position peaked at $20.1K in Q4 2023.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on HCR Wealth Advisors's 13F filing for Q1 2024, filed 10 May 2024.